Tirzepatide access
Novi vs Mochi Health: Which One Offers Tirzepatide? (2026)
Novi or Mochi Health? Side-by-side 2026 pricing, medication and service comparison, extended to six and twelve-month totals.
Published · Pricing as published in our provider dataset, synced · Editorial scores 7.0 and 7.0 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
The choice between Novi and Mochi Health usually comes down to one difference that neither homepage puts in its headline.
Only one of these two gives you a route to tirzepatide. Novi offers it at $166/mo; Mochi Health publishes a semaglutide program only, which caps where treatment can go if semaglutide underdelivers.
The comparison below starts from published pricing, converts it into annual cost, and then asks what the more expensive side is delivering for the difference. Gaps in a provider's disclosure are reported as gaps, because they are part of what you are buying.
The short answer
- Lowest ongoing rate
- Mochi Health — $99/mo against $133/mo, though only one of the two publishes enough to total a full year.
- Most support for the money
- Mochi Health — 24/7 support plus ongoing appointments throughout the program.
- Tirzepatide access
- Novi — Tirzepatide at $166/mo; the other side publishes semaglutide only.
- Easiest to pay for
- Novi — Neither publishes financing; both expect the full amount monthly.
The short version: Novi vs Mochi Health
The rows below are the ones that differ enough between these two to be worth your attention.
| Novi | Mochi Health | |
|---|---|---|
| Advertised price | Semaglutide from $133/mo, tirzepatide from $166/mo | Membership plus medication from $99/mo, 50% off the first month |
| Rate after promotions | $133/mo | $99/mo |
| Pricing structure | Published rate per medication | Membership fee plus the cost of medication |
| Medication | Compounded semaglutide and compounded tirzepatide | Compounded GLP-1 |
| Tirzepatide | $166/mo | Not published |
| Membership fee | None | Yes, billed separately |
| How fast you start | Online intake | Live video visit with a doctor, bookable in about 5 minutes |
| State coverage | Not published | All 50 states |
| Price transparency | Published upfront | Partly published |
| Patient reviews | 50,124 | 36,124 |
| eRxDoctor score | 7.0/10 | 7.0/10 |
What you will have spent by month twelve
Comparing entry prices across these two would be actively misleading, because they escalate differently. Here is what each one costs across a realistic course of treatment, on published pricing.
| Novi | Mochi Health | |
|---|---|---|
| First month | $133 | $99 |
| Months 2 onward | $133/mo | Not published |
| 6-month total | $798 | Not computable |
| 12-month total | $1,596 | Not computable |
| Best published plan | No multi-month discount published | No multi-month discount published |
A like-for-like annual total is not available for Mochi Health: total monthly cost is membership plus medication and varies by plan and medication. Treat any comparison that quotes one as an estimate someone else has made for you.
Semaglutide, tirzepatide, and having somewhere to go next
Semaglutide is a GLP-1 receptor agonist. Tirzepatide adds GIP activity, and in head-to-head trial data it has produced larger average weight reductions. That does not make it the right first choice for everyone — it is typically more expensive and the side-effect profile is its own conversation — but it is the usual next step when semaglutide underdelivers.
Novi publishes both, with tirzepatide at $166/mo. Mochi Health publishes compounded GLP-1, so switching molecules would mean switching provider, repeating an intake and losing whatever pricing you had locked in.
If you are confident semaglutide is where you will stay, this difference costs you nothing. If you are not, it is worth more than a small monthly saving.
Novi: what you are buying
$200 OFF - GLP-1 for $133 Today What it is really selling here is the narrowest gap here between semaglutide and tirzepatide pricing, at $133 and $166.
You start with online intake; medication arrives via free 2-day shipping with every order. The price behaves as published rate per medication.
Ongoing care is no long-term contract, cancel anytime, and the medication list runs to compounded semaglutide and compounded tirzepatide.
Novi pros
- No insurance required and no long-term contract, cancel anytime
- $200 off promotion brings GLP-1 to $133 today
- Largest patient base on this list, 50,000+ patients, signaling operational maturity
- Competitive pricing: semaglutide from $133/month and tirzepatide from $166/month
Novi cons
- Tirzepatide ($166) costs more than the semaglutide entry rate
- Compounded medication only, no branded Ozempic, Wegovy, or Zepbound
- No published outcome or weight loss guarantee
Against Mochi Health specifically, the trade you are making: the $133 rate depends on a $200-off promotion and there is no outcome guarantee.
A closer look at Mochi Health
50% Off Your 1st Month with Code BESTWLHALFOFF In this pairing, its distinguishing feature is a live video visit with a doctor in about five minutes, where most competitors run an asynchronous text review.
The process is live video visit with a doctor, bookable in about 5 minutes, then home delivery. On money, expect membership fee plus the cost of medication — partly published.
Support: 24/7 support plus ongoing appointments throughout the program. The medications on offer are compounded GLP-1.
Mochi Health pros
- 50% off your first month with code BESTWLHALFOFF
- Live video visits with a doctor, bookable in about 5 minutes (most competitors do async text review)
- 24/7 support plus ongoing appointment availability throughout your program
- Reliable GLP-1 prescription access in all 50 states
Mochi Health cons
- Pricing is membership plus medication, so total monthly cost varies by plan and medication
- Ongoing pricing is less transparent than flat-rate competitors
- Compounded medication focus, branded options not the primary offering
The cost of choosing this over Novi: membership-plus-medication pricing is harder to forecast than a flat rate.
Picking between them
Choose Novi if:
- you want tirzepatide available without changing provider later
- you want the full price in front of you before completing an intake
- you want a single monthly charge rather than a membership plus medication
- what it leads on is worth paying for in your case: the narrowest gap here between semaglutide and tirzepatide pricing, at $133 and $166
Choose Mochi Health if:
- the level of clinical contact suits you: 24/7 support plus ongoing appointments throughout the program
- you would get real value from a live video visit with a doctor in about five minutes, where most competitors run an asynchronous text review
- you are in a state where GLP-1 telehealth coverage is patchy
- the monthly rate is the constraint — $99/mo against $133/mo
What each one gives up
On price. The monthly gap is 34% in Mochi Health's favor. Whether that is a saving or a false economy turns on one thing: membership-plus-medication pricing is harder to forecast than a flat rate.
On clinical contact. No long-term contract, cancel anytime at Novi; 24/7 support plus ongoing appointments throughout the program at Mochi Health. Neither is a substitute for in-person care if you have complicating conditions, and both bill you directly rather than your insurer.
On medication. Novi covers compounded semaglutide and compounded tirzepatide; Mochi Health covers compounded GLP-1. Only Novi publishes a tirzepatide route, which matters if semaglutide underdelivers.
On access. Novi advertises online intake and free 2-day shipping with every order; Mochi Health advertises live video visit with a doctor, bookable in about 5 minutes and home delivery. Coverage differs too — not published against all 50 states — which decides the question before price does if you are in a restricted state.
The medication, not the platform
Neither Novi nor Mochi Health manufactures the molecule it prescribes, and the clinical evidence behind GLP-1 treatment belongs to the drug rather than to any platform selling access to it.
Cardiovascular benefit has been demonstrated for semaglutide in a specific population: adults with overweight or obesity and existing cardiovascular disease but no diabetes, per NEJM, SELECT.
In SURMOUNT-4, stopping tirzepatide after a lead-in period produced significant weight regain, where staying on it did not, per JAMA, SURMOUNT-4.
Neither platform's marketing changes any of that. It is the same evidence base whichever one takes your card.
Novi vs Mochi Health: common questions
Is Mochi Health cheaper than Novi?
Yes, on the ongoing rate. Mochi Health runs $99/mo once promotional pricing ends, against $133/mo at Novi — a difference of 34%. Compare the first-month offers separately, because both providers discount entry differently from the rate you will actually be paying by month three.
Can I switch from Novi to Mochi Health later?
Yes. Neither program locks you in clinically, and both operate month to month unless you have bought a multi-month plan. Practically, switching means a fresh intake, a fresh clinician review and possibly a gap in supply, so time it against your current shipment rather than your renewal date.
Do Novi and Mochi Health prescribe the same medication?
Both dispense compounded GLP-1 preparations. Novi lists compounded semaglutide and compounded tirzepatide and Mochi Health lists compounded GLP-1, so the molecules overlap even where the formulary does not match exactly.
Does Novi or Mochi Health charge a membership fee?
Mochi Health runs a membership-plus-medication model, so the monthly total is the membership plus whatever the medication costs on your plan. Novi charges $133/mo with no separate membership. When comparing the two, price the membership model at your expected maintenance dose rather than at the introductory rate.
How fast can I start with Novi compared with Mochi Health?
Novi advertises online intake, with free 2-day shipping with every order. Mochi Health advertises live video visit with a doctor, bookable in about 5 minutes, with home delivery. Both are subject to clinician review and to whether your state and health history clear, so treat the advertised timeline as a best case rather than a commitment.
Which has more patient reviews, Novi or Mochi Health?
Novi, with 50,124 against 36,124. Ratings across this market cluster tightly, so volume is the more useful signal: it indicates how much operational load the platform has already absorbed, not how good the medication is.
The verdict
Mochi Health is the cheaper of the two to run at $99/mo, but a full-year total is only computable for one side of this comparison, so treat that as a directional finding rather than a settled one.
Novi's case is the narrowest gap here between semaglutide and tirzepatide pricing, at $133 and $166; its cost: the $133 rate depends on a $200-off promotion and there is no outcome guarantee.
Neither choice is irreversible. Start with the program whose weaknesses you can tolerate, and reassess at month three when you know how you respond to the medication.
Keep comparing
- Novi vs MaximusLarge platform vs smaller platform
- Novi vs He & She MDCoaching-supported vs medication-only
- Mochi Health vs Elevate HealthTirzepatide access
- Mochi Health vs TMatesBudget vs premium
- Elevate Health vs TMatesTirzepatide access
- Refills vs MaximusTirzepatide access
See every provider in context on the weight loss rankings, or browse the full comparison index.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what each provider published as of the sync date above and changes frequently; confirm the current rate, and the rate at your maintenance dose, before you pay. Six- and twelve-month totals are calculated from those published rates and exclude anything a provider bills separately.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by Novi or Mochi Health, and does not sell treatment. Read our ranking methodology.